Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions.

Roberts JA, Abdul-Aziz MH, Lipman J, Mouton JW, Vinks AA, Felton TW, Hope WW, Farkas A, Neely MN, Schentag JJ, Drusano G, Frey OR, Theuretzbacher U, Kuti JL; International Society of Anti-Infective Pharmacology and the Pharmacokinetics and Pharmacodynamics Study Group of the European Society of Clinical Microbiology and Infectious Diseases..

Lancet Infect Dis. 2014 Jun;14(6):498-509. doi: 10.1016/S1473-3099(14)70036-2. Epub 2014 Apr 24. Review.

2.

Individualization of piperacillin dosing for critically ill patients: dosing software to optimize antimicrobial therapy.

Felton TW, Roberts JA, Lodise TP, Van Guilder M, Boselli E, Neely MN, Hope WW.

Antimicrob Agents Chemother. 2014 Jul;58(7):4094-102. doi: 10.1128/AAC.02664-14. Epub 2014 May 5.

3.

Using PK/PD to optimize antibiotic dosing for critically ill patients.

Roberts JA.

Curr Pharm Biotechnol. 2011 Dec;12(12):2070-9. Review.

PMID:
21554211
4.

Optimizing dosing of antibiotics in critically ill patients.

Parker SL, Sime FB, Roberts JA.

Curr Opin Infect Dis. 2015 Dec;28(6):497-504. doi: 10.1097/QCO.0000000000000206. Review.

PMID:
26382000
5.

The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients.

Ulldemolins M, Roberts JA, Rello J, Paterson DL, Lipman J.

Clin Pharmacokinet. 2011 Feb;50(2):99-110. doi: 10.2165/11539220-000000000-00000. Review.

PMID:
21142293
6.

Clinical implications of antibiotic pharmacokinetic principles in the critically ill.

Udy AA, Roberts JA, Lipman J.

Intensive Care Med. 2013 Dec;39(12):2070-82. doi: 10.1007/s00134-013-3088-4. Epub 2013 Sep 18. Review.

PMID:
24045886
7.

Antibiotic dosing in critically ill patients with acute kidney injury.

Eyler RF, Mueller BA; Medscape..

Nat Rev Nephrol. 2011 Apr;7(4):226-35. doi: 10.1038/nrneph.2011.12. Epub 2011 Feb 22. Review.

PMID:
21343897
8.

How can we ensure effective antibiotic dosing in critically ill patients receiving different types of renal replacement therapy?

Jamal JA, Mueller BA, Choi GY, Lipman J, Roberts JA.

Diagn Microbiol Infect Dis. 2015 May;82(1):92-103. doi: 10.1016/j.diagmicrobio.2015.01.013. Epub 2015 Feb 2.

PMID:
25698632
9.

DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients?

Roberts JA, Paul SK, Akova M, Bassetti M, De Waele JJ, Dimopoulos G, Kaukonen KM, Koulenti D, Martin C, Montravers P, Rello J, Rhodes A, Starr T, Wallis SC, Lipman J; DALI Study..

Clin Infect Dis. 2014 Apr;58(8):1072-83. doi: 10.1093/cid/ciu027. Epub 2014 Jan 14.

PMID:
24429437
10.

Pharmacokinetic/pharmacodynamic considerations for the optimization of antimicrobial delivery in the critically ill.

Tsai D, Lipman J, Roberts JA.

Curr Opin Crit Care. 2015 Oct;21(5):412-20. doi: 10.1097/MCC.0000000000000229. Review.

PMID:
26348420
11.

How severe is antibiotic pharmacokinetic variability in critically ill patients and what can be done about it?

Felton TW, Hope WW, Roberts JA.

Diagn Microbiol Infect Dis. 2014 Aug;79(4):441-7. doi: 10.1016/j.diagmicrobio.2014.04.007. Epub 2014 Apr 30. Review.

PMID:
24985764
12.

Monte Carlo simulations: maximizing antibiotic pharmacokinetic data to optimize clinical practice for critically ill patients.

Roberts JA, Kirkpatrick CM, Lipman J.

J Antimicrob Chemother. 2011 Feb;66(2):227-31. doi: 10.1093/jac/dkq449. Epub 2010 Nov 30.

PMID:
21118912
13.

Right dose, right now: using big data to optimize antibiotic dosing in the critically ill.

Elbers PW, Girbes A, Malbrain ML, Bosman R.

Anaesthesiol Intensive Ther. 2015;47(5):457-63. doi: 10.5603/AIT.a2015.0061. Epub 2015 Oct 13. Review.

14.

Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients.

De Waele JJ, Lipman J, Akova M, Bassetti M, Dimopoulos G, Kaukonen M, Koulenti D, Martin C, Montravers P, Rello J, Rhodes A, Udy AA, Starr T, Wallis SC, Roberts JA.

Intensive Care Med. 2014 Sep;40(9):1340-51. doi: 10.1007/s00134-014-3403-8. Epub 2014 Jul 23. Erratum in: Intensive Care Med. 2015 May;41(5):969. Dosage error in article text.

PMID:
25053248
15.

What is the relevance of fosfomycin pharmacokinetics in the treatment of serious infections in critically ill patients? A systematic review.

Parker S, Lipman J, Koulenti D, Dimopoulos G, Roberts JA.

Int J Antimicrob Agents. 2013 Oct;42(4):289-93. doi: 10.1016/j.ijantimicag.2013.05.018. Epub 2013 Jul 20. Review.

PMID:
23880170
16.

[Pharmacokinetics and pharmacodynamics of antibiotic therapy].

Beck S, Wicha SG, Kloft C, Kees MG.

Anaesthesist. 2014 Oct;63(10):775-82. doi: 10.1007/s00101-014-2369-9. Review. German.

PMID:
25150263
17.

Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study.

Roberts DM, Roberts JA, Roberts MS, Liu X, Nair P, Cole L, Lipman J, Bellomo R; RENAL Replacement Therapy Study Investigators..

Crit Care Med. 2012 May;40(5):1523-8. doi: 10.1097/CCM.0b013e318241e553.

PMID:
22511133
18.

Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy.

Ulldemolins M, Vaquer S, Llauradó-Serra M, Pontes C, Calvo G, Soy D, Martín-Loeches I.

Crit Care. 2014 Jun 23;18(3):227. doi: 10.1186/cc13938. Review.

19.

Pharmacokinetics of meropenem in critically ill patients with severe infections.

Binder L, Schwörer H, Hoppe S, Streit F, Neumann S, Beckmann A, Wachter R, Oellerich M, Walson PD.

Ther Drug Monit. 2013 Feb;35(1):63-70. doi: 10.1097/FTD.0b013e31827d496c.

PMID:
23318279
20.

Pharmacological principles of antibiotic prescription in the critically ill.

Pinder M, Bellomo R, Lipman J.

Anaesth Intensive Care. 2002 Apr;30(2):134-44. Review.

Supplemental Content

Support Center